159 related articles for article (PubMed ID: 25855725)
1. Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer.
Pérez-Gómez E; Andradas C; Blasco-Benito S; Caffarel MM; García-Taboada E; Villa-Morales M; Moreno E; Hamann S; Martín-Villar E; Flores JM; Wenners A; Alkatout I; Klapper W; Röcken C; Bronsert P; Stickeler E; Staebler A; Bauer M; Arnold N; Soriano J; Pérez-Martínez M; Megías D; Moreno-Bueno G; Ortega-Gutiérrez S; Artola M; Vázquez-Villa H; Quintanilla M; Fernández-Piqueras J; Canela EI; McCormick PJ; Guzmán M; Sánchez C
J Natl Cancer Inst; 2015 Jun; 107(6):djv077. PubMed ID: 25855725
[TBL] [Abstract][Full Text] [Related]
2. The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Moreno E; Cavic M; Krivokuca A; Casadó V; Canela E
Front Pharmacol; 2019; 10():339. PubMed ID: 31024307
[TBL] [Abstract][Full Text] [Related]
3. Expression of c-erb-B2 oncoprotein as a neoantigen strategy to repurpose anti-neu antibody therapy in a model of melanoma.
Gabriel EM; Necela B; Bahr D; Vivekanandhan S; Shreeder B; Bagaria S; Knutson KL
Res Sq; 2024 Apr; ():. PubMed ID: 38645250
[TBL] [Abstract][Full Text] [Related]
4. Dihydroceramide desaturase 1 (DES1) promotes anchorage-independent survival downstream of HER2-driven glucose uptake and metabolism.
Linzer RW; Guida DL; Aminov J; Snider JM; Khalife G; Buyukbayraktar AB; Alhaddad C; Resnick AE; Wang P; Pan CH; Allopenna JJ; Clarke CJ
FASEB J; 2022 Oct; 36(10):e22558. PubMed ID: 36165222
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival.
Martínez-Martínez E; Gómez I; Martín P; Sánchez A; Román L; Tejerina E; Bonilla F; Merino AG; de Herreros AG; Provencio M; García JM
Oncoscience; 2015; 2(2):131-41. PubMed ID: 25859556
[TBL] [Abstract][Full Text] [Related]
6. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
McAllister SD; Soroceanu L; Desprez PY
J Neuroimmune Pharmacol; 2015 Jun; 10(2):255-67. PubMed ID: 25916739
[TBL] [Abstract][Full Text] [Related]
7. Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.
Elbaz M; Ahirwar D; Ravi J; Nasser MW; Ganju RK
Oncotarget; 2017 May; 8(18):29668-29678. PubMed ID: 27213582
[TBL] [Abstract][Full Text] [Related]
8. The use of cannabinoids as anticancer agents.
Velasco G; Hernández-Tiedra S; Dávila D; Lorente M
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():259-66. PubMed ID: 26071989
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoids and Cancer.
Velasco G; Sánchez C; Guzmán M
Handb Exp Pharmacol; 2015; 231():449-72. PubMed ID: 26408171
[TBL] [Abstract][Full Text] [Related]
10. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279
[TBL] [Abstract][Full Text] [Related]
11. Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner.
Nabissi M; Morelli MB; Amantini C; Liberati S; Santoni M; Ricci-Vitiani L; Pallini R; Santoni G
Int J Cancer; 2015 Oct; 137(8):1855-69. PubMed ID: 25903924
[TBL] [Abstract][Full Text] [Related]
12. A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.
Feliú A; Moreno-Martet M; Mecha M; Carrillo-Salinas FJ; de Lago E; Fernández-Ruiz J; Guaza C
Br J Pharmacol; 2015 Jul; 172(14):3579-95. PubMed ID: 25857324
[TBL] [Abstract][Full Text] [Related]
13. The complex modulation of lysosomal degradation pathways by cannabinoid receptors 1 and 2.
Hiebel C; Behl C
Life Sci; 2015 Oct; 138():3-7. PubMed ID: 25908257
[TBL] [Abstract][Full Text] [Related]
14. CB1 receptors modulate affective behaviour induced by neuropathic pain.
Rácz I; Nent E; Erxlebe E; Zimmer A
Brain Res Bull; 2015 May; 114():42-8. PubMed ID: 25863168
[TBL] [Abstract][Full Text] [Related]
15. The current state and future perspectives of cannabinoids in cancer biology.
Śledziński P; Zeyland J; Słomski R; Nowak A
Cancer Med; 2018 Mar; 7(3):765-775. PubMed ID: 29473338
[TBL] [Abstract][Full Text] [Related]
16. Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent.
Hanlon KE; Lozano-Ondoua AN; Umaretiya PJ; Symons-Liguori AM; Chandramouli A; Moy JK; Kwass WK; Mantyh PW; Nelson MA; Vanderah TW
Breast Cancer (Dove Med Press); 2016; 8():59-71. PubMed ID: 27186076
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid and ceramide levels are altered in patients with colorectal cancer.
Chen L; Chen H; Li Y; Li L; Qiu Y; Ren J
Oncol Rep; 2015 Jul; 34(1):447-54. PubMed ID: 25975960
[TBL] [Abstract][Full Text] [Related]
18. Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection.
More SV; Choi DK
Mol Neurodegener; 2015 Apr; 10():17. PubMed ID: 25888232
[TBL] [Abstract][Full Text] [Related]
19. Appraising the "entourage effect": Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer.
Blasco-Benito S; Seijo-Vila M; Caro-Villalobos M; Tundidor I; Andradas C; García-Taboada E; Wade J; Smith S; Guzmán M; Pérez-Gómez E; Gordon M; Sánchez C
Biochem Pharmacol; 2018 Nov; 157():285-293. PubMed ID: 29940172
[TBL] [Abstract][Full Text] [Related]
20. Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis.
Sophocleous A; Marino S; Logan JG; Mollat P; Ralston SH; Idris AI
J Biol Chem; 2015 Sep; 290(36):22049-60. PubMed ID: 26195631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
